Evidence map›Paper›PMID 38012417›Full record

ArticleNature immunology2024

FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells.

Ziang Zhu, Guohua Lou, Xiao-Lu Teng, Haixia Wang, Ying Luo, Wangke Shi, Kiddist Yihunie, Shumeng Hao, Kole DeGolier, Chengheng Liao and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. FOXP1 Knockdown Reprograms Th9 CAR-T Cells to Overcome Antigen Escape.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. Generation of CCR4/CD7 Bispecific CAR-T Cells Resistant to Fratricide and Exhaustion.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CAR.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  12. Maternal Krüppel-like factor 2 (KLF2)+ CD4 T cells promote fertility and fetal tolerance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. KLF2 overrides the resident memory CD8 T cell differentiation program, in opposition to KLF3.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Ziang Zhu *Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Guohua Lou *Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Xiao-Lu Teng *Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Haixia WangDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ying LuoDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wangke ShiDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Kiddist YihunieDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-0863-4863
Shumeng HaoDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kole DeGolierDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID http://orcid.org/0000-0002-4144-7277
Chengheng LiaoDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Huocong HuangDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Qing ZhangDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-6595-8995
Terry FryDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Tao WangQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-4355-149X
Chen YaoDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA. chen.yao@utsouthwestern.edu.ORCID http://orcid.org/0000-0001-6852-5661
Tuoqi WuDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA. tuoqi.wu@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-4003-1034
The University of Texas Southwestern Medical Center · USUniversity of Colorado Anschutz Medical Campus · USSouthwestern Medical Center · US

Funding

Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infectionR01AI158294 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Tuoqi Wu · 2022 to 2026
$2.9M
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV ReservoirsDP2AI154450 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI YAO, CHEN · 2021 to 2025
$2.5M
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cellsR00AG056524 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI WU, TUOQI · 2019 to 2021
$733k
Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunityR21AG083398 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI WU, TUOQI · 2023 to 2024
$451k
NIAID NIH HHS DP2 AI154450NIAID NIH HHS R01 AI158294NIA NIH HHS K99 AG056524NIA NIH HHS R00 AG056524NIA NIH HHS R21 AG083398
6 · The paper itself

Abstract

In cancer and infections, self-renewing stem-like CD8

Indexed as

CD8-Positive T-LymphocytesTranscription FactorsCell DifferentiationChromatinT-Lymphocyte SubsetsChromatinTranscription Factors

Identifiers

PMID38012417
PMCPMC10841689
OpenAlexW4389045621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.